POSTDOCTORAL POSITIONS in ALZHEIMER’S DISEASE RESEARCH at DFCI-HMS
The Cantor lab is recruiting postdoctoral fellows to participate in a collaborative research program focused on developing immune-based therapy to modify the development of Alzheimer’s disease. We use genetic, biochemical, and cell-based approaches to study disease in several animal models for these investigations. Successful candidates will receive joint appointments at the Dana-Farber Cancer Institute and the Harvard Medical School. The program offers substantial scientific resources within a stimulating and collegial research environment.
Highly-motivated candidates with a PhD, MD or MD/PhD in neurological sciences and experience in immunology, molecular biology and/or biochemistry are encouraged to apply. Prior experience using murine models of Alzheimer’s disease, including histological and microscopic analysis of disease is strongly preferred. Candidates should have a strong record of scientific accomplishment. A CV, bibliography and research interest summary should be sent to Harvey Cantor c/o firstname.lastname@example.org.
DFCI is an Equal Opportunity Employer.
Women and minorities are strongly encouraged to apply.
The information in this e-mail is intended only for the person to whom it is addressed. If you believe this e-mail was sent to you in error and the e-mail contains patient information, please contact the Partners Compliance HelpLine at http://www.partners.org/complianceline. If the e-mail was sent to you in error but does not contain patient information, please contact the sender and properly dispose of the e-mail.